The quality of reporting randomized controlled trials in the dermatology literature in an era where the CONSORT statement is a standard.

Several critical items in reporting RCTs, including allocation concealment, similarity of interventions in blinded trials and prospective trial registration, have remained unsatisfactory in the recent dermatology literature.